Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Occupational risk factors may be of importance to define populations suitable to screening of lung cancer Source: Annual Congress 2011 - Work, the environment and respiratory disease Year: 2011
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Source: Eur Respir J 2010; 35: 146-151 Year: 2010
Biomarkers of lung cancer in a general population sample: distribution and relationship with risk factors for respiratory disorders Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003
Respiratory function and the risk of lung cancer in COPD patients: A population-based cohort study Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey Source: ERJ Open Res, 6 (1) 00158-2019; 10.1183/23120541.00158-2019 Year: 2020
Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005
Evaluation of cancer-associated thrombosis risk in patients with lung adenocarcinoma using the COMPASS-CAT risk assessment model Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer? Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011
Lung cancer–CT screening performed in a high risk portuguesese population Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Lung cancer in patients with COPD: Incidence and predicting factors Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011
What is real prevalence of COPD in patients with lung cancer? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016 Year: 2017
Prevalence and burden of bronchiectasis in a lung cancer screening program Source: International Congress 2019 – Airway infection in COPD Year: 2019
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019